dc.contributor.author | Guven, G.S | |
dc.contributor.author | Kiliçaslan, A | |
dc.contributor.author | Oz, S.G | |
dc.contributor.author | Haznedaroglu, I.C | |
dc.contributor.author | Kirazli, S | |
dc.contributor.author | Aslan, D | |
dc.contributor.author | Sözen, T. | |
dc.date.accessioned | 2019-12-10T11:11:30Z | |
dc.date.available | 2019-12-10T11:11:30Z | |
dc.date.issued | 2006 | |
dc.identifier.uri | https://doi.org/10.1177/1076029606291403 | |
dc.identifier.uri | https://www.scopus.com/inward/record.url?eid=2-s2.0-33748741980&partnerID=40&md5=6ab7af02f031072603ce4bc9ba313365 | |
dc.identifier.uri | http://hdl.handle.net/11655/14970 | |
dc.relation.isversionof | 10.1177/1076029606291403 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Decrements In The Thrombin Activatable Fibrinolysis Inhibitor (Tafi) Levels In Association With Orlistat Treatment In Obesity | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.relation.journal | Clinical and Applied Thrombosis/Hemostasis | |
dc.contributor.department | İç Hastalıkları | |
dc.identifier.volume | 12 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 364 | |
dc.identifier.endpage | 368 | |
dc.description.index | Scopus | |